Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6114)
All Articles published online
|
Publishing Process of This Article
|
Dec 27, 2020 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ahn KS, Kang KJ. Molecular heterogeneity in intrahepatic cholangiocarcinoma. World J Hepatol 2020; 12(12): 1148-1157 [PMID: 33442444 DOI: 10.4254/wjh.v12.i12.1148] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v12/i12/1148.htm |
| Number | Citing Articles |
| 1 |
R. Sheng, B. Zheng, Y. Zhang, W. Sun, C. Yang, Y. Ding, J. Zhou, M. Zeng. “Very early” intrahepatic cholangiocarcinoma (≤ 2.0 cm): MRI manifestation and prognostic potential. Clinical Radiology 2024; 79(8): 608 doi: 10.1016/j.crad.2024.05.005
|
| 2 |
Nurbubu T. Moldogazieva, Sergey P. Zavadskiy, Dmitry V. Astakhov, Susanna S. Sologova, Arus G. Margaryan, Anastasiya A. Safrygina, Elena A. Smolyarchuk. Differentially expressed non-coding RNAs and their regulatory networks in liver cancer. Heliyon 2023; 9(9): e19223 doi: 10.1016/j.heliyon.2023.e19223
|
| 3 |
Alice Boilève, Marc Hilmi, Matthieu Delaye, Annemilaï Tijeras-Raballand, Cindy Neuzillet. Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?. Cancers 2021; 13(11): 2708 doi: 10.3390/cancers13112708
|
| 4 |
Ashish Manne, Edward Woods, Allan Tsung, Arjun Mittra. Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.768009
|
| 5 |
Li Ma, Xiang Li. Meeting report of the editorial board meeting for <i>World Journal of Hepatology </i>2021. World Journal of Hepatology 2021; 13(2): 162-165 doi: 10.4254/wjh.v13.i2.162
|
| 6 |
P. Padmavathi, Anagha S. Setlur, K. Chandrashekar, Vidya Niranjan. A comprehensive in-silico computational analysis of twenty cancer exome datasets and identification of associated somatic variants reveals potential molecular markers for detection of varied cancer types. Informatics in Medicine Unlocked 2021; 26: 100762 doi: 10.1016/j.imu.2021.100762
|
| 7 |
Purva Gopal, Marie E. Robert, Xuchen Zhang. Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision Medicine. Archives of Pathology & Laboratory Medicine 2024; 148(3): 359 doi: 10.5858/arpa.2022-0537-RA
|
| 8 |
Masayuki Akita, Hiroaki Yanagimoto, Daisuke Tsugawa, Yoh Zen, Takumi Fukumoto. Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review. Surgery Today 2024; doi: 10.1007/s00595-024-02825-x
|
| 9 |
Francesco Vasuri, Marzia Deserti, Angelo G. Corradini, Simona Tavolari, Valeria Relli, Andrea Palloni, Giorgio Frega, Stefania Curti, Stefano Mattioli, Matteo Cescon, Antonia D’Errico, Giovanni Brandi. Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-27791-1
|
| 10 |
Hossein Taghizadeh, Theresa Schmalfuss, Agnieszka Maj-Hes, Josef Singer, Gerald W. Prager. Austrian tricentric real-life analysis of molecular profiles of metastatic biliary tract cancer patients. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1143825
|
| 11 |
Marcello Moro Queiroz, Nildevande Firmino Lima, Tiago Biachi de Castria. Immunotherapy and Targeted Therapy for Advanced Biliary Tract Cancer: Adding New Flavors to the Pizza. Cancers 2023; 15(7): 1970 doi: 10.3390/cancers15071970
|
| 12 |
Ruofan Sheng, Xiaoyong Huang, Kaipu Jin, Shanshan Gao, Mengsu Zeng, Dong Wu, Guoming Shi. Contrast-enhanced MRI could predict response of systemic therapy in advanced intrahepatic cholangiocarcinoma. European Radiology 2022; 32(8): 5156 doi: 10.1007/s00330-022-08679-6
|
| 13 |
Lei Zhang, Donglai Ma, Fujun Li, Gongcai Qiu, Dongsheng Sun, Zhaolin Zeng. Lnc-PKD2-2-3/miR-328/GPAM ceRNA Network Induces Cholangiocarcinoma Proliferation, Invasion and 5-FU Chemoresistance. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.871281
|
| 14 |
Laura Alaimo, Sara Boggio, Giovanni Catalano, Giuseppe Calderone, Edoardo Poletto, Mario De Bellis, Tommaso Campagnaro, Corrado Pedrazzani, Simone Conci, Andrea Ruzzenente. Multi-Omics Classification of Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Cancers 2024; 16(14): 2596 doi: 10.3390/cancers16142596
|